About us
We at cecava are dedicated to advancing cancer treatment with personalized and hence more effective immunotherapies that put each patient first. This is achieved through the adoption of cutting-edge technologies to tailor our vaccines to the unique characteristics of each patient’s tumor, with the ultimate goal of improving the lives of cancer patients worldwide.
Changing the Future of GBM Care: One Patient at a Time
Glioblastoma (GBM) is one of the deadliest cancers, stealing lives in as little as 15-17 months, with only 5% of patients surviving five years. Families watch their loved ones lose not just time, but also independence and quality of life, while treatments offer little more than borrowed months. At cecava, we’re fighting to change this with Individualized Peptide Cancer Therapy (INPECT)
